Viennese biotech company Marinomed Biotechnologie has licensed the rights of five drugs to a global pharmaceutical firm for the Chinese market. The drugs include three antiviral nasal sprays against common cold, influenza and colds in ...
Merck has signed a licensing agreement with AiCuris for the worldwide development and commercialisation rights of candidates in AiCuris' Human Cytomegalovirus (HCMV) portfolio. The HCMV portfolio includes letermovir (AIC246), an oral, ...